Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease

SMT Vestjens, EAM Sanders, BJ Vlaminckx… - Vaccine, 2019 - Elsevier
Abstract Introduction In 2006, the Netherlands introduced the 7-valent pneumococcal
conjugate vaccine (PCV7) in their national immunisation programme. In 2011, PCV7 was …
被引用次数：30 相关文章

Twelve years of pneumococcal conjugate vaccination in the Netherlands: impact on incidence and clinical outcomes of invasive pneumococcal disease.

SMT Vestjens, EAM Sanders, BJ Vlaminckx, HE Melker… - 2019 - cabidigitallibrary.org
Abstract Introduction: In 2006, the Netherlands introduced the 7-valent pneumococcal
conjugate vaccine (PCV7) in their national immunisation programme. In 2011, PCV7 was …

Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease

SMT Vestjens, EAM Sanders… - …, 2019 - researchinformation.amsterdamumc …
Abstract Introduction: In 2006, the Netherlands introduced the 7-valent pneumococcal
conjugate vaccine (PCV7) in their national immunisation programme. In 2011, PCV7 was …

[引用][C] Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease.

SMT Vestjens, EAM Sanders, BJ Vlaminckx… - 2019 - rivm.openrepository.com
Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence
and clinical outcomes of invasive pneumococcal disease. Toggle navigation Login Toggle …

Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease

SMT Vestjens, EAM Sanders, BJ Vlaminckx… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction In 2006, the Netherlands introduced the 7-valent pneumococcal conjugate
vaccine (PCV7) in their national immunisation programme. In 2011, PCV7 was replaced by …

Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease.

SMT Vestjens, EAM Sanders, BJ Vlaminckx… - Vaccine, 2019 - europepmc.org
Methods Pneumococcal isolates of hospitalised IPD patients between June 2004 and May
2018 were obtained from nine sentinel laboratories, covering 25% of the Dutch population …

[引用][C] Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease

SMT Vestjens, EAM Sanders, BJ Vlaminckx… - 2019